Nuvama Wealth Finance Limited

About Nuvama Wealth Finance Limited bond with ISIN: INE918K07IP2

In the competitive landscape of fixed income securities, detailed and comprehensive information is vital for both investors and market analysts. This bond, identified by the unique ISIN INE918K07IP2, represents a significant financial instrument. Issued by NUVAMA WEALTH FINANCE LIMITED, it comes with the following description: "NIFTY 50 LINKED SECURED UNRATED UNLISTED NON PRINCIPAL PROTECTED MARKET LINKED REDEEMABLE NON CONVERTIBLE DEBENTURES. SERIES K4B205A. DATE OF MATURITY 07/07/2025". Although the bond is currently marked as active, its structure and historical context provide valuable insights into the world of debentures and non-convertible securities. The issuer, NUVAMA WEALTH FINANCE LIMITED, classified as Non PSU, plays an essential role in the market despite some details such as sector, industry, and issuer nature not being explicitly provided. Key identifiers like the Corporate Identification Number (CIN) U67120MH1994PLC286057 further bolster its credibility. With a coupon rate of NIFTY 50 LINKED, this instrument has been meticulously managed with the assistance of KFIN TECHNOLOGIES PRIVATE LIMITED and under the oversight of SBICAP Trustee Company Limited, ensuring a strong operational framework. Examining the technical specifications, the bond’s face value is 100000 with an issue size of 50. It was allotted on 2/22/2022 and is scheduled for redemption on 7/7/2025. Categorized under "Structured/Market Linked Debentures (MLDs)" and defined as Secured, the instrument is structured to meet specific investment objectives. Although options such as call or put are not applicable in this instance, the core attributes remain detailed and robust. A critical element in evaluating any fixed income instrument is its credit rating. No credit rating information is available for this bond. This insight helps potential investors understand that while the ratings spectrum is broad, a lower rating can indicate higher risk, prompting careful consideration before investing. The security measures add another layer of assurance. The asset cover is described as follows: THE DEBENTURES SHALL BE SECURED BY WAY OF A PARI PASSU MORTGAGE AND CHARGE OVER THE MORTGAGE PREMISES AS DEFINED IN THE DEBENTURE TRUST DEED; A CHARGE BY WAY OF HYPOTHECATION ON THE RECEIVABLES, STOCK IN TRADE, LOANS AND INVESTMENTS TO THE EXTENT EQUAL TO THE PRINCIPAL AND INTEREST AMOUNTS OF THE DEBENTURES OUTSTANDING AT ANY POINT OF TIME. THE SECURITY WAS ALREADY CREATED PURSUANT TO THE DEBENTURE TRUST DEED DATED MAY 10, 2019.FOR MORE DETAILS PLEASE CONTACT TO ISSUER. – a feature that, while requiring further inquiry for complete details, underscores the issuer’s commitment to providing some level of investor protection. Furthermore, the bond is supported by several documents. There are no additional documents available for this bond. These documents serve as a reference for additional details and provide transparency to interested parties. Additionally, there are similar bonds in the market such as the bond with ISIN INE918K07PS1 having a coupon rate of 9.85 and the bond with ISIN INE918K07OJ3 having a coupon rate of Nifty 50 Index and the bond with ISIN INE918K07NC0 having a coupon rate of Nifty 50 Index and the bond with ISIN INE918K07KE2 having a coupon rate of Nifty 50 Index. Such comparable instruments offer a broader perspective on market positioning and allow investors to perform benchmark analysis. This detailed description is crafted to meet rigorous content standards and to offer exhaustive insights into every facet of the bond’s structure. Investors, analysts, and researchers alike can derive substantial value from this narrative, which underscores both the instrument’s inherent characteristics and its broader market positioning. Such elaborate coverage enhances investor confidence by providing a rich, comprehensive content base. Every element from issuance details to security measures and comparative insights is meticulously presented to facilitate an informed and robust market understanding.